Health
Researchers to test monoclonal antibodies against COVID-19 – Mirage News
Getty Images “We need a treatment that is effective,” said infectious disease physician Ann Collier, who is leading the trial at UW Medicine. UW…
UW Medicine is one of a network of U.S. sites testing a new treatment for COVID-19 that involves monoclonal antibodies, which are intended to provide immediate antiviral activity that lasts several weeks.
The drug is part of the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, sponsored by the National Institute of Allergy and Infectious Diseases. The trial is also receiving support from Operation Warp Speed, the U.S. government’s multi-agency effort to help end the pandemic….
-
Noosa News22 hours agoYoung voices shape Sunshine Coast’s future
-
Business22 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News21 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News20 hours agoAnother All-Star Cast, Another Tale of Family Chaos: The Trailer for Wes Anderson’s ‘The Phoenician Scheme’ Is Here